A Posterior-Eye Drug Delivery System for Treatment of Age-Related Macular Degeneration
thermally sensitive gel. This gel undergoes a phase transition characterized by a lower critical solution temperature (LCST) of 33oC, below which the drug is loaded in the gel and above

